# OnCo record nct07051785 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07051785/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07051785", "NCT07051785" ;
  schema:name "Fruquintinib vs Bevacizumab Combined With Irinotecan Liposome and Capecitabine as Second-Line Therapy for Advanced Metastatic Colorectal Cancer"@en ;
  schema:alternateName "ARK"@en ;
  schema:description "A phase 2 trial of fruquintinib, capecitabine and bevacizumab (glioblastoma use) in colorectal cancer, run by Liu Huang, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07051785/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07051785> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/fruquintinib/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/bevacizumab-glioma/> .